CARES Act Carryback for Net Operating Losses
The CARES Act gives companies a five-year carryback period for NOLs arising in the 2018, 2019, and 2020 tax years. Under the timing rules of the Internal Revenue Code (“IRC”) Section 172 and the promulgated Treasury Regulations, the carried back NOLs are carried to the earliest of the tax years to which the loss may be carried.
CARES Act Taxable Income Offset
Additionally, the CARES Act suspends the 80% of taxable income limitation on the use of NOLs for tax years beginning before January 1, 2021. The TCJA imposed the 80% of taxable income limitation on the use of NOLs, which applied to years beginning after December 31, 2017. As a result of the CARES Act, corporate taxpayers may use NOLs to fully offset taxable income in the 2018, 2019, and 2020 tax years.
The below table summarizes three categories of federal NOLs that are effectively created as a result of the TCJA and CARES Act:
|NOL generated||Carryback(tax years)||Carryforward(tax years)||Can offset % of
|On or prior to
December 31, 2017
|After December 31, 2017,
and before January 1, 2021
|5||Indefinite||100% (prior to 2021)80% (after 2020)|
|On or after
January 1, 2021
COVID-19 Tax Savings
As a result of the changes to federal NOL provisions, corporate taxpayers may be able to amend prior year returns to offset pre-2018 income that was taxed at higher tax rates of up to 35% (the TCJA changed the corporate income tax rate to 21%). This will generate a current year refund for companies and provide them with additional cash flow and liquidity. Corporations with NOLs generated pre-2021 tax year will be able to completely offset their taxable income for the 2018, 2019, and 2020 tax years and allocate the tax savings to other expenses arising out of the COVID-19 emergency.
If you have any questions about this post or any other related matters, please feel free to contact me at email@example.com.
We will be keeping you informed about the CARES Act of 2020 through this “Inside the CARES Act” series on our Biz Law Blog. For other topics related to COVID-19, visit our Coronavirus Thought Leadership Connection.